Centro de Tratamento Oncologico LTDA - CTO

Belém, Pará 66073-005

0 studies enrolling now · 1 studies all time

What they study most

Triple Negative Breast Cancer

Studies at this site

• Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC — Running, not enrolling